Office for Nuclear Regulation

Category: Amersham – GE Healthcare

Site Stakeholder Group (SSG) reports for Q3 – 2023

October 17, 2023 -


Site Stakeholder Group (SSG) reports for Q2 – 2023

August 1, 2023 -


The Grove Centre – Amersham – Inspection ID: 52371

May 9, 2023 - Executive summary Date(s) of inspection: March 2023 Aim of inspection The aim of the inspection is to review any changes to the company’s governance arrangements and its capability and capacity against the requirements of LC17 and LC36. Subject(s) of inspection LC 17 – Management systems – Rating: GREEN LC 36 – Organisational capability – Rating: […]


GE Healthcare Ltd, Amersham – Inspection ID: 52058

February 24, 2023 - Executive summary Date(s) of inspection: December 2022 Aim of inspection This inspection will target the implementation of the licensee’s LC32 arrangements. The outcome sought is a reduction in waste accumulation at the site since the last inspection. Subject(s) of inspection LC32 – Accumulation of radioactive waste – Rating: Green Key findings, inspector’s opinions and reasons […]


GE Healthcare Amersham – Site Stakeholder Group (SSG) reports for Q4 2021 – Q3 2022

December 23, 2022 -


GE Healthcare Amersham – Project Assessment Report (PAR): 21-017

September 13, 2022 -


GE Healthcare, Amersham – Inspection ID: 22-040

August 8, 2022 - Site: GE Healthcare, Amersham IR number: 22-040 Date: June 2022 LC numbers: 7 Executive summary Purpose of Intervention This inspection, one of a series of planned inspections for 2022/23 at the GE Healthcare Ltd Grove Centre licensed nuclear site, was undertaken to judge compliance with Licence Condition (LC) 7 – Incidents on the site. Interventions […]


Site Stakeholder Group (SSG) reports for Q3 – 2021

November 8, 2021 -


Site Stakeholder Group (SSG) reports for Q3 – 2020

November 23, 2020 -


Site Stakeholder Group reports for Q3 2019

October 11, 2019 -